Catalyst Pharmaceuticals Inc Financial Flexibility Index
Catalyst Pharmaceuticals Inc financial flexibility index. Catalyst Pharmaceuticals Inc (CPRX) has a Financial Flexibility Index of 0.44x as of March 2026. Free cash flow of $59.61 Million (operating CF $59.59 Million minus capex $27.00K) represents 0% of total liabilities ($134.91 Million). See Catalyst Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Catalyst Pharmaceuticals Inc (2004–2025)
Financial flexibility index of Catalyst Pharmaceuticals Inc from 2004 to 2025. Historical Financial Flexibility Index trend for Catalyst Pharmaceuticals Inc across 22 annual periods. Check CPRX cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Catalyst Pharmaceuticals Inc Financial Flexibility Index by Year (2004–2025)
Catalyst Pharmaceuticals Inc financial flexibility index by year from 2004 to 2025. Year-by-year free cash flow to debt coverage for Catalyst Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Catalyst Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.37x | $208.73 Million | $208.67 Million | $152.54 Million | ▼ -29.5% |
| 2024 | 1.94x | $240.36 Million | $239.81 Million | $123.78 Million | ▼ -29.1% |
| 2023 | 2.74x | $225.34 Million | $143.60 Million | $82.23 Million | ▲ +77.6% |
| 2022 | 1.54x | $116.08 Million | $116.05 Million | $75.21 Million | ▼ -22.2% |
| 2021 | 1.98x | $61.39 Million | $60.37 Million | $30.96 Million | ▲ +0.2% |
| 2020 | 1.98x | $45.05 Million | $45.03 Million | $22.76 Million | ▲ +41.5% |
| 2019 | 1.40x | $34.63 Million | $34.61 Million | $24.75 Million | ▲ +152.8% |
| 2018 | -2.65x | $-25.61 Million | $-25.70 Million | $9.67 Million | ▲ +14.1% |
| 2017 | -3.09x | $-13.65 Million | $-13.74 Million | $4.42 Million | ▲ +58.6% |
| 2016 | -7.45x | $-17.87 Million | $-17.96 Million | $2.40 Million | ▼ -91.6% |
| 2015 | -3.89x | $-17.99 Million | $-18.02 Million | $4.63 Million | ▼ -161.6% |
| 2014 | -1.49x | $-12.88 Million | $-12.94 Million | $8.67 Million | ▲ +40.0% |
| 2013 | -2.48x | $-9.87 Million | $-9.88 Million | $3.98 Million | ▼ -5.6% |
| 2012 | -2.35x | $-5.09 Million | $-5.14 Million | $2.17 Million | ▼ -17.3% |
| 2011 | -2.00x | $-4.98 Million | $-4.99 Million | $2.49 Million | ▲ +83.3% |
| 2010 | -11.97x | $-3.75 Million | $-3.76 Million | $313.71K | ▲ +45.7% |
| 2009 | -22.04x | $-7.68 Million | $-7.68 Million | $348.52K | ▼ -293.0% |
| 2008 | -5.61x | $-8.26 Million | $-8.26 Million | $1.47 Million | ▲ +54.1% |
| 2007 | -12.20x | $-4.36 Million | $-4.42 Million | $357.17K | ▼ -714.9% |
| 2006 | -1.50x | $-1.16 Million | $-1.18 Million | $772.85K | ▼ -13.8% |
| 2005 | -1.32x | $-451.42K | $-455.36K | $342.99K | ▲ +61.0% |
| 2004 | -3.37x | $-228.69K | $-230.52K | $67.80K | — |